Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.
about
Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causationSulfation of the human immunodeficiency virus envelope glycoproteinA New Scientific Paradigm may be Needed to Finally Develop an HIV VaccineQuantitative measurement of fusion between human immunodeficiency virus and cultured cells using membrane fluorescence dequenchingHuman monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1Protein intrinsic disorder toolbox for comparative analysis of viral proteins.Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization.An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120The N-terminal region of the human immunodeficiency virus envelope glycoprotein gp120 contains potential binding sites for CD4.Binding site for human immunodeficiency virus coat protein gp120 is located in the NH2-terminal region of T4 (CD4) and requires the intact variable-region-like domain.95- and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptorInduction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles.Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeysThe SU and TM envelope protein subunits of bovine leukemia virus are linked by disulfide bonds, both in cells and in virionsHuman immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1.Human immunodeficiency virus type 1 major neutralizing determinant exposed on hepatitis B surface antigen particles is highly immunogenic in primatesDiscontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoproteinVaccine protection against simian immunodeficiency virus infection.Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.Solid-phase proteoliposomes containing human immunodeficiency virus envelope glycoproteins.Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion.Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cellsModifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization.Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine.A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope.Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attackSpecific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.An HIV-1 envelope immunogen with W427S mutation in CD4 binding site induced more T follicular helper memory cells and reduced non-specific antibody responses.Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope proteinHIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B.Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand.Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies.Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41.
P2860
Q24627627-69F1263E-C2CD-40F6-9FDE-FEB79702C3C6Q24647955-48A50428-8855-41AC-AB49-BCBC19452BF7Q26830360-6025E933-A6C8-43BC-9EEF-029CE171BB3CQ28646804-983ECEBA-5DC4-488C-B7EC-A8160FEBB5E2Q29619512-DEF1D26E-C212-45A2-90C1-6215F9FBCFDBQ33373579-7FDE497E-2C89-40DE-9413-66B9A1E218A1Q33560772-E3E6863E-090F-43B7-A772-922122FC1524Q33567984-B307A805-E721-4C2C-BEB1-8E922544EDEBQ33570776-A75056E7-554F-4219-A328-A8A32FEFFEC0Q33571605-17B0BB0A-4871-42E0-AE94-5443073F28BCQ33579510-F44FF200-B910-42C2-BEEB-7774C929FBEFQ33641132-11687B61-2853-4E1E-B34D-839D00A004F5Q33645518-D516B880-FB97-4F28-B842-361F863E50FCQ33660809-7FB7C2A0-DCCF-4656-AA93-EB16718EF58AQ33785114-CE27D32D-6832-44A8-91A2-DB51EC4E27B0Q33800644-ED3FEDA5-DDCA-49C9-905C-071693717861Q33832289-2EAEF025-EADA-4A4C-8A47-28E5DFAAA4FCQ33933855-8492BAB8-F663-4937-932A-7E4D8B7B1241Q33937274-93D4F7B7-3A94-4BD9-80AB-00AAA3228324Q34298187-794D87F3-7823-4F8B-8483-8BFD43D05487Q34301897-C6BAFDF1-7E09-4D68-9C1A-7FFC40DB72A8Q34334135-7BE2AB97-1104-40F6-AE1F-F0F777836392Q34335264-2C5F63C6-564C-4E85-95E7-F0F13CFC8C3FQ34350730-9E63CD7F-BF96-42E9-A056-AA9C07D3330CQ34363707-BA64442C-1BCB-418E-BA4B-C44BF8776F7BQ34373003-3DE1BD0E-0877-440B-ABEE-FA4ED6BCC281Q34614992-B82FACC0-F73E-481B-8FC6-A2EA262D09F5Q34628114-A89232A9-1739-4309-9512-58AA809D471BQ34632476-5732CFD1-8DE5-443D-93B6-3DE8314FDAE1Q34636237-F1A96B7D-8C58-4358-ACF5-A83DA36FF7BBQ34640420-A6A4BA7F-2CAD-4E72-98AF-99346B51CF47Q34784825-43E5D842-67CC-43F0-AB17-3632F1FE4838Q34787140-242AC952-9793-467E-868F-2B4CB80281D4Q35173635-9F86B45A-012C-4124-A2CF-494F05A699ADQ35763321-31507626-466A-4B74-AB16-20BF133A120AQ35828898-8ADA1EC1-DA80-479E-B5A9-BF48F89C6DBDQ35844007-4ED9A8B3-62B0-44B1-A737-04210C00692DQ35854300-E454DE25-6513-4FC3-8627-B059A8C24139Q35930918-36D1243A-9060-4520-BA22-1543D0846072Q36230737-2505C3C0-A788-4B8B-BE30-B6E34AB9621B
P2860
Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1986
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prospect for prevention of hum ...... induces neutralizing antibody.
@en
Prospect for prevention of hum ...... induces neutralizing antibody.
@nl
type
label
Prospect for prevention of hum ...... induces neutralizing antibody.
@en
Prospect for prevention of hum ...... induces neutralizing antibody.
@nl
prefLabel
Prospect for prevention of hum ...... induces neutralizing antibody.
@en
Prospect for prevention of hum ...... induces neutralizing antibody.
@nl
P2093
P2860
P356
P1476
Prospect for prevention of hum ...... induces neutralizing antibody.
@en
P2093
A Langlois
D P Bolognesi
L O Arthur
N W Lerche
P J Fischinger
R V Gilden
S Oroszlan
T D Copeland
T J Matthews
P2860
P304
P356
10.1073/PNAS.83.18.7023
P407
P577
1986-09-01T00:00:00Z